GLMD Form 6-K: Report of foreign private issuer, 2020

GALMED PHARMACEUTICALS LTD. Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

2020-12-17: Form 6-K; Period of report 2020-12-17; Description 6-K; Document tm2038790d1_6k.htm.
2020-11-12: Form 6-K; Period of report 2020-11-12; Description FORM 6-K; Document tm2035693-1_6k.htm.
2020-11-09: Form 6-K; Period of report 2020-11-09; Description FORM 6-K; Document tm2035416d1_6k.htm.
2020-09-09: Form 6-K; Period of report 2020-09-09; Description FORM 6-K; Document tm2030474d1_6k.htm.

Filed	Form	Period of report	Description	Document
2020-12-17	6-K	2020-12-17	6-K	tm2038790d1_6k.htm
2020-11-12	6-K	2020-11-12	FORM 6-K	tm2035693-1_6k.htm
2020-11-09	6-K	2020-11-09	FORM 6-K	tm2035416d1_6k.htm
2020-09-09	6-K	2020-09-09	FORM 6-K	tm2030474d1_6k.htm
2020-08-14	6-K	2020-08-14	FORM 6-K	tm2027643d1_6k.htm
2020-08-06	6-K	2020-06-30	FORM 6-K	tm2025410d1_6k.htm
2020-07-08	6-K	2020-07-08	FORM 6-K	tm2024355d1_6k.htm
2020-06-19	6-K	2020-06-19	FORM 6-K	tm2023002d1_6k.htm
2020-05-21	6-K	2020-05-21	FORM 6-K	tm2020587-1_6k.htm
2020-05-18	6-K	2020-05-18	FORM 6-K	tm2020067d1_6k.htm
2020-05-15	6-K	2020-05-15	FORM 6-K	tm2019897d1_6k.htm
2020-05-14	6-K	2020-05-14	FORM 6-K	tm2019662d1_6k.htm
2020-03-12	6-K	2020-03-12	FORM 6-K	tm206796d3_6k.htm